School of Medicine Publications and Presentations
Document Type
Article
Publication Date
1-2012
Abstract
Curcumin, a natural diphenolic compound derived from turmeric Curcuma longa, has proven to be a modulator of intracellular signaling pathways that control cancer cell growth, inflammation, invasion, apoptosis and cell death, revealing its anticancer potential. In this review, we focus on the design and development of nanoparticles, self-assemblies, nanogels, liposomes and complex fabrication for sustained and efficient curcumin delivery. We also discuss the anticancer applications and clinical benefits of nanocurcumin formulations. Only a few novel multifunctional and composite nanosystem strategies offer simultaneous therapy as well as imaging characteristics. We also summarize the challenges to developing curcumin delivery platforms and up-to-date solutions for improving curcumin bioavailability and anticancer potential for therapy.
Recommended Citation
Yallapu, M. M., Jaggi, M., & Chauhan, S. C. (2012). Curcumin nanoformulations: a future nanomedicine for cancer. Drug discovery today, 17(1-2), 71–80. https://doi.org/10.1016/j.drudis.2011.09.009
Publication Title
Drug Discov Today
Academic Level
faculty
Mentor/PI Department
Immunology and Microbiology
Comments
© 2011 Elsevier Ltd. All rights reserved.